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Morphine is one of the most potent analgesic drugs used to relieve moderate to severe 
pain. After long-term use of morphine, neuroadaptive changes in the brain promotes 
tolerance, which result in a reduced sensitivity to most of its effects with attenuation of 
analgesic efficacy, and dependence, revealed by drug craving and physical or 
psychological manifestations of drug withdrawal. The mu opioid receptor (MOR) is 
critical, not only in mediating morphine analgesia, but also in addictive behaviors by the 
induction of a strong rewarding effect. We have previously shown that dopamine D4 
receptor (D4R) stimulation counteracts morphine-induced activation of dopaminergic 
nigrostriatal pathway and accumulation of Fos family transcription factors in the 
caudate putamen (CPu). 
In the present work, we have studied the effect of D4R activation on MOR changes 
induced by morphine in the rat CPu on a continuous drug treatment paradigm, by 
analyzing MOR protein level, pharmacological profile, and functional coupling to G 
proteins. Furthermore, using conditioned place preference and withdrawal syndrome 
test, we have investigated the role of D4R activation on morphine-related behavioural 
effects.  
MOR immunoreactivity, agonist binding density and its coupling to G proteins are up-
regulated in the striosomes by continuous morphine treatment. Interestingly, co-
treatment of morphine with the dopamine D4 receptor (D4R) agonist PD168,077 fully 
counteracts these adaptive changes in MOR, in spite of the fact that continuous 
PD168,077 treatment increases the [3H]DAMGO Bmax values to the same degree as 
seen after continuous morphine treatment. In addition, the administration of the D4R 
agonist counteracts the rewarding effects of morphine, as well as the development of 
physical dependence. The present results give support for the existence of antagonistic 
functional D4R-MOR receptor-receptor interactions in the adaptive changes occurring 
in MOR of striosomes on continuous administration of morphine and preventing 
morphine-related behaviour. 
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